SEARCH
Enter your search term below:
Close
Enter your search term below:
WORLD LEADING BUSINESS SUPPORT
Attomarker Ltd is a spin-out company from the University of Exeter, founded to develop a novel, label-free, array-based technology to monitor concentrations of large numbers of biomarkers in the blood to provide a differential diagnosis of disease to assist the clinical decision makers. Multiple simultaneous biomarker analysis of blood chemistry points to a new direction in diagnosis for complex conditions such as allergy or irritable bowel syndrome, or the recovery of patients from operations. The multi-marker analysis provides a view of the health of a patient, an allergy profile or a novel way to follow the recovery of a patient after a surgical procedure.
Get all the fresh insights first! Stay up-to-date with all the
latest investment news, blogs and all things SETsquared.
Close
Did you know @MyNestBox are making property purchasing informed, simple & enjoyable?
Read about this new prop t… twitter.com/i/web/status/13674…
Our Scale-Up Programme supports companies and researchers to bid for funding calls across five themes and there are… twitter.com/i/web/status/13674…
As part of the #InnovateLocal Southern Pioneers event, on the 9 March SETsquared will host an Innovation masterclas… twitter.com/i/web/status/13673…
Have you considered what the new normal will look like? How you can make your business more robust? @UniOfSurrey a… twitter.com/i/web/status/13671…
Don't miss out twitter.com/UoS_KTP/status/136…
SETsquared is a partnership between